Eyenovia (EYEN) Expected to Announce Earnings on Wednesday

Eyenovia (NASDAQ:EYEN) will likely be releasing its Q4 2024 earnings data before the market opens on Wednesday, May 21st. Analysts expect the company to announce earnings of ($7.20) per share and revenue of $1.60 million for the quarter.

Eyenovia Price Performance

NASDAQ EYEN opened at $1.15 on Wednesday. Eyenovia has a twelve month low of $0.85 and a twelve month high of $124.80. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.55 and a current ratio of 0.74. The stock has a market capitalization of $3.25 million, a PE ratio of -0.02 and a beta of 0.76. The stock has a 50-day simple moving average of $1.20 and a 200 day simple moving average of $7.35.

Analyst Upgrades and Downgrades

Separately, HC Wainwright reaffirmed a “neutral” rating and issued a $2.00 price target on shares of Eyenovia in a research report on Friday, March 21st.

Eyenovia Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.